|
|
||||||||
Ann Thorac Surg 2006;82:1835-1841
© 2006 The Society of Thoracic Surgeons
a Department of Surgery, University of Virginia, Charlottesville, Virginia
b Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia
c Department of Internal Medicine, University of Virginia, Charlottesville, Virginia
Accepted for publication May 11, 2006.
* Address correspondence to Dr Jones, Department of Surgery, University of Virginia, PO Box 800679, Charlottesville, VA 22908-0679 (Email: djones{at}virginia.edu).
Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30Feb 2, 2006.
BACKGROUND: Advanced recipient age is reported to negatively affect survival after lung transplantation (LTX). We hypothesized that LTX in patients aged
60 years could be performed with acceptable outcomes.
METHODS: We identified 182 consecutive LTX recipients from 1995 to 2005. Outcomes were analyzed and survival compared with results in recipients aged <60, as well as with United Network for Organ Sharing (UNOS) registry outcomes for the same age and study period. Actuarial survivals were calculated by the Kaplan-Meier method.
RESULTS: During the study period, 29% (52/182) of LTX recipients were
60 years old (range, 60 to 69 years). Median follow-up was 2.9 years (range, 0 to 10 years). All patients but one received a single lung. Indications included chronic obstructive pulmonary disease in 63% (33/52), idiopathic pulmonary fibrosis in 27% (14/52), and other in 10% (5/52). In-hospital mortality was 12% (6/52) for those aged
60 compared with 7% (9/130) for those aged <60 (p = NS). Complications included reoperation in 10% (5/52), requirement for extracorporeal membrane oxygenation in 6% (3/52), renal failure in 12% (6/52), and stroke in 4% (2/52). Actuarial survivals at 30 days, and 1, 3, and 5 years were 90% (82, 98), 86% (76, 96), 71% (56, 85), and 55% (37, 73), respectively. No significant difference in survival was observed between age cohorts for our institutional data by Kaplan-Meier analysis (p = 0.34) or by Cox proportional hazard model (p = 0.15). A significant survival advantage was noted for our institution compared with UNOS for this cohort (p = 0.018).
CONCLUSIONS: In carefully selected recipients
60 years of age, LTX offers acceptable outcomes and survival.
This article has been cited by other articles:
![]() |
R. Mahidhara, S. Bastani, D. J. Ross, R. Saggar, J. Lynch III, G. T. Schnickel, D. Gjertson, R. Beygui, and A. Ardehali Lung transplantation in older patients? J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 412 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri Update in Chronic Obstructive Pulmonary Disease 2006 Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |